Prostamax 20mg bioregulator peptide
Prostamax is a short synthetic bioregulator peptide (C20H33N5O9, 487.5 g/mol) associated with prostate tissue in the research literature. This listing is a 20mg vial.
Specification
| Quantity per vial | 20mg |
|---|---|
| Molecular formula | C20H33N5O9 |
| Molecular weight | 487.5 g/mol |
| Stated purity | ≥99% (HPLC) |
| Form | Lyophilised solid |
| Storage | 2–8°C, sealed, protected from light and moisture |
Research background
Short peptides of this kind come mostly from the bioregulator research programme of Vladimir Khavinson and colleagues in St Petersburg. Prostamax has been studied for its effects on chromatin condensation in lymphocyte cultures and in prostate-derived cell lines. The work is preclinical, and Prostamax is not an approved medicine.
Further reading: search PubMed for published studies on Prostamax.
Storage and handling
Store the vial unopened at 2–8°C, dry and out of direct light. Bring it to room temperature before opening so moisture does not condense on the solid. Follow your laboratory’s protocols for solvent choice and for storing any prepared solution.
Related products
Prostamax is listed in our Bioregulator Peptides range. Related products include Testagen 20mg, Cartalax 20mg – Bioregulator and Pancragen 10mg. For reconstitution and sample storage, see our laboratory supplies.
For laboratory research use only. Not for human or veterinary use. Not a medicine, food, supplement or cosmetic.
Reviews
There are no reviews yet.